Clinical trials / NCT02990858
NCT02990858Phase 2, phase 3Terminated

An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study

Study sponsor: CytoDyn, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2022-06Actual
Enrollment · participants43Actual
Source updated2025-11-12Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 4 fields changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Compare wording
− Before

Measure: Mean change in viral load (HIV-1 RNA levels) at the conclusion of treatment period

+ After

Measure: Mean Change in Viral Load (HIV-1 RNA Levels) at the Conclusion of Treatment Period

Actual enrollment decreased by 1 participants

− Before

44 participants (actual)

+ After

43 participants (actual)

Completion date type changed

− Before

Estimated

+ After

Actual

Recruitment status changed

− Before

Active not recruiting

+ After

Terminated

Check registry source